Metabolomic signatures of intestinal colonization resistance against Campylobacter jejuni in mice

Introduction Campylobacter jejuni stands out as one of the leading causes of bacterial enteritis. In contrast to humans, specific pathogen-free (SPF) laboratory mice display strict intestinal colonization resistance (CR) against C. jejuni, orchestrated by the specific murine intestinal microbiota, as shown by fecal microbiota transplantation (FMT) earlier. Methods Murine infection models, comprising SPF, SAB, hma, and mma mice were employed. FMT and microbiota depletion were confirmed by culture and culture-independent analyses. Targeted metabolome analyses of fecal samples provided insights into the associated metabolomic signatures. Results In comparison to hma mice, the murine intestinal microbiota of mma and SPF mice (with CR against C. jejuni) contained significantly elevated numbers of lactobacilli, and Mouse Intestinal Bacteroides, whereas numbers of enterobacteria, enterococci, and Clostridium coccoides group were reduced. Targeted metabolome analysis revealed that fecal samples from mice with CR contained increased levels of secondary bile acids and fatty acids with known antimicrobial activities, but reduced concentrations of amino acids essential for C. jejuni growth as compared to control animals without CR. Discussion The findings highlight the role of microbiota-mediated nutrient competition and antibacterial activities of intestinal metabolites in driving murine CR against C. jejuni. The study underscores the complex dynamics of host-microbiota-pathogen interactions and sets the stage for further investigations into the mechanisms driving CR against enteric infections.

[1]  S. Backert,et al.  Molecular Targets in Campylobacter Infections , 2023, Biomolecules.

[2]  S. Hapfelmeier,et al.  Mouse models for bacterial enteropathogen infections: insights into the role of colonization resistance , 2023, Gut microbes.

[3]  A. Hitchcock,et al.  Cysteine Biosynthesis in Campylobacter jejuni: Substrate Specificity of CysM and the Dualism of Sulfide , 2022, Biomolecules.

[4]  M. Heimesaat,et al.  Human microbiota associated IL-10−/− mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota , 2022, European journal of microbiology & immunology.

[5]  M. Heimesaat,et al.  Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam , 2022, European journal of microbiology & immunology.

[6]  T. Ndung’u,et al.  Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation , 2022, Nature Microbiology.

[7]  M. Heimesaat,et al.  Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10−/− Mice with the Probiotic Formulation Aviguard® , 2021, Microorganisms.

[8]  S. Backert,et al.  Human Campylobacteriosis—A Serious Infectious Threat in a One Health Perspective , 2021, Current topics in microbiology and immunology.

[9]  P. Schrotz-King,et al.  Evaluation of different stool extraction methods for metabolomics measurements in human faecal samples , 2020, medRxiv.

[10]  S. Cordwell,et al.  Proteomics of Campylobacter jejuni Growth in Deoxycholate Reveals Cj0025c as a Cystine Transport Protein Required for Wild-type Human Infection Phenotypes , 2020, Molecular & Cellular Proteomics.

[11]  M. Heimesaat,et al.  Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis , 2020, Microorganisms.

[12]  C. L. Fischer,et al.  Antimicrobial Activity of Host-Derived Lipids , 2020, Antibiotics.

[13]  A. Okoh,et al.  Human campylobacteriosis: A public health concern of global importance , 2019, Heliyon.

[14]  Jiafeng Lu,et al.  Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases , 2019, Journal of Zhejiang University-SCIENCE B.

[15]  U. Sauer,et al.  Escherichia coli limits Salmonella Typhimurium infections after diet-shifts and fat-mediated microbiota perturbation in mice , 2019, Nature Microbiology.

[16]  E. Kuijper,et al.  Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection , 2019, Microbiology and Molecular Biology Reviews.

[17]  S. Backert,et al.  Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model , 2019, Gut Pathogens.

[18]  Y. Kwon,et al.  Microbial metabolite deoxycholic acid shapes microbiota against Campylobacter jejuni chicken colonization , 2019, bioRxiv.

[19]  M. Heimesaat,et al.  Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers , 2019, European journal of microbiology & immunology.

[20]  Lori A. S. Snyder,et al.  Alternative antimicrobials: the properties of fatty acids and monoglycerides , 2018, Critical reviews in microbiology.

[21]  A. Fodor,et al.  Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice. , 2018, Gastroenterology.

[22]  Joshua A. Jackman,et al.  Antibacterial Free Fatty Acids and Monoglycerides: Biological Activities, Experimental Testing, and Therapeutic Applications , 2018, International journal of molecular sciences.

[23]  P. Lund,et al.  In Vitro Antibacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureus , 2017, Front. Microbiol..

[24]  J. Bardowski,et al.  In vitro characteristics of Lactobacillus spp. strains isolated from the chicken digestive tract and their role in the inhibition of Campylobacter colonization , 2017, MicrobiologyOpen.

[25]  S. Morjaria,et al.  Commensal microbes provide first line defense against Listeria monocytogenes infection , 2017, The Journal of experimental medicine.

[26]  R. Thanissery,et al.  Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. , 2017, Anaerobe.

[27]  K. Stingl,et al.  Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infection , 2017, Scientific Reports.

[28]  M. Blaser,et al.  Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice , 2016, Gut Pathogens.

[29]  M. Ferchichi,et al.  Purification and Characterization of a Novel Anti-Campylobacter Bacteriocin Produced by Lactobacillus curvatus DN317 , 2016, Probiotics and Antimicrobial Proteins.

[30]  Henry C. Lin,et al.  Fatty acids from diet and microbiota regulate energy metabolism , 2015, F1000Research.

[31]  Si Ming Man,et al.  Global Epidemiology of Campylobacter Infection , 2015, Clinical Microbiology Reviews.

[32]  B. White,et al.  The Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal Dissemination in Mice , 2015, Applied and Environmental Microbiology.

[33]  Wei Chen,et al.  Screening of adhesive lactobacilli with antagonistic activity against Campylobacter jejuni , 2014 .

[34]  D. Hofreuter Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuni , 2014, Front. Cell. Infect. Microbiol..

[35]  D. Schomburg,et al.  Utilization of host‐derived cysteine‐containing peptides overcomes the restricted sulphur metabolism of Campylobacter jejuni , 2014, Molecular microbiology.

[36]  M. Stahl,et al.  A Novel Mouse Model of Campylobacter jejuni Gastroenteritis Reveals Key Pro-inflammatory and Tissue Protective Roles for Toll-like Receptor Signaling during Infection , 2014, PLoS pathogens.

[37]  C. Hill,et al.  Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut , 2014, Proceedings of the National Academy of Sciences.

[38]  U. Göbel,et al.  Impact of Campylobacter jejuni cj0268c Knockout Mutation on Intestinal Colonization, Translocation, and Induction of Immunopathology in Gnotobiotic IL-10 Deficient Mice , 2014, PloS one.

[39]  Paul S. Cohen,et al.  Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine , 2013, PloS one.

[40]  A. Walker,et al.  Intestinal colonization resistance , 2013, Immunology.

[41]  F. Pasmans,et al.  Screening for lactic acid bacteria capable of inhibiting Campylobacter jejuni in in vitro simulations of the broiler chicken caecal environment. , 2012, Beneficial microbes.

[42]  U. Göbel,et al.  Intestinal Microbiota Shifts towards Elevated Commensal Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in Mice , 2012, PloS one.

[43]  U. Göbel,et al.  Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. , 2012, European journal of microbiology & immunology.

[44]  U. Göbel,et al.  Novel Murine Infection Models Provide Deep Insights into the “Ménage à Trois” of Campylobacter jejuni, Microbiota and Host Innate Immunity , 2011, PloS one.

[45]  D. Donoghue,et al.  Water administration of the medium-chain fatty acid caprylic acid produced variable efficacy against enteric Campylobacter colonization in broilers. , 2011, Poultry science.

[46]  Qijing Zhang,et al.  Phenotypic and Genotypic Evidence for l-Fucose Utilization by Campylobacter jejuni , 2010, Journal of bacteriology.

[47]  D. Donoghue,et al.  Caprylic Acid reduces enteric campylobacter colonization in market-aged broiler chickens but does not appear to alter cecal microbial populations. , 2010, Journal of food protection.

[48]  M. Gareau,et al.  Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. , 2009, FEMS microbiology letters.

[49]  H. Ingmer,et al.  Energy Taxis Drives Campylobacter jejuni toward the Most Favorable Conditions for Growth , 2009, Applied and Environmental Microbiology.

[50]  R. D. Wagner,et al.  Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice. , 2009, Molecular nutrition & food research.

[51]  Jeffrey D Goldsmith,et al.  A mouse model of Clostridium difficile-associated disease. , 2008, Gastroenterology.

[52]  F. Haesebrouck,et al.  Short-chain fatty acids and l-lactate as feed additives to control Campylobacter jejuni infections in broilers , 2008, Avian pathology : journal of the W.V.P.A.

[53]  W. Willis,et al.  Investigating the effects of dietary probiotic feeding regimens on broiler chicken production and Campylobacter jejuni presence. , 2008, Poultry science.

[54]  G. Frankel,et al.  Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. , 2006, FEMS microbiology letters.

[55]  Jeff F. Miller,et al.  Campylobacter jejuni Colonization of Mice with Limited Enteric Flora , 2006, Infection and Immunity.

[56]  L. Du,et al.  Unique Features of a Highly Pathogenic Campylobacter jejuni Strain , 2006, Infection and Immunity.

[57]  M. Williamson,et al.  The Campylobacter jejuni PEB1a adhesin is an aspartate/glutamate‐binding protein of an ABC transporter essential for microaerobic growth on dicarboxylic amino acids , 2006, Molecular microbiology.

[58]  A. Yokota,et al.  Mechanism of Growth Inhibition by Free Bile Acids in Lactobacilli and Bifidobacteria , 2006, Journal of bacteriology.

[59]  J. Hancock,et al.  Role of Xanthine Oxidoreductase as an Antimicrobial Agent , 2004, Infection and Immunity.

[60]  P. Barrow,et al.  l-Serine Catabolism via an Oxygen-Labile l-Serine Dehydratase Is Essential for Colonization of the Avian Gut by Campylobacter jejuni , 2004, Infection and Immunity.

[61]  O. Sahin,et al.  Critical Role of Multidrug Efflux Pump CmeABC in Bile Resistance and In Vivo Colonization of Campylobacter jejuni , 2003, Infection and Immunity.

[62]  P. Mangell,et al.  Lactobacillus plantarum 299v Inhibits Escherichia coli-Induced Intestinal Permeability , 2002, Digestive Diseases and Sciences.

[63]  J. Garssen,et al.  Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats. , 2002, International journal of food microbiology.

[64]  R. van der Meer,et al.  Bactericidal Activities of Milk Lipids , 2001, Antimicrobial Agents and Chemotherapy.

[65]  J. Galán,et al.  A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. , 2000, Science.

[66]  A. Hinton,et al.  Use of oleic acid to reduce the population of the bacterial flora of poultry skin. , 2000, Journal of food protection.

[67]  A. Hofmann,et al.  The continuing importance of bile acids in liver and intestinal disease. , 1999, Archives of internal medicine.

[68]  P. Aye,et al.  Evaluation of an avian-specific probiotic to reduce the colonization and shedding of Campylobacter jejuni in broilers. , 1997, Avian diseases.

[69]  D. Brassart,et al.  The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo , 1997, Applied and environmental microbiology.

[70]  E. Lesaffre,et al.  Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria , 1996, Applied and environmental microbiology.

[71]  M. C. Peterson Clinical aspects of Campylobacter jejuni infections in adults. , 1994, The Western journal of medicine.

[72]  M. Doyle,et al.  Chemotactic behavior of Campylobacter jejuni , 1988, Infection and immunity.

[73]  H. Oda,et al.  Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids , 1981, Applied and environmental microbiology.

[74]  M. Heimesaat,et al.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections. , 2021, Current topics in microbiology and immunology.

[75]  S. Backert,et al.  Campylobacter Virulence Factors and Molecular Host-Pathogen Interactions. , 2021, Current topics in microbiology and immunology.

[76]  D. Donoghue,et al.  The natural feed additive caprylic acid decreases Campylobacter jejuni colonization in market-aged broiler chickens. , 2009, Poultry science.

[77]  D. Maskell,et al.  Metabolite and transcriptome analysis of Campylobacter jejuni in vitro growth reveals a stationary-phase physiological switch. , 2009, Microbiology.